Peter Justin Klein

CIK 1608710 · last filed 2021-06-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.65M

Companies

2

Total Filings

26

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PhaseBio Pharmaceuticals Inc (PHAS) Delisted Director 2,303 $0.07 $161 $0 5 2021-06-04
SENS Director 369,186 $7.18 $2.65M $0 21 2021-04-05

Recent Filings · Page 2 of 3

26 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-10-02 SENS Grant (A) +6,758 $6.4K EDGAR
2019-07-03 SENS Grant (A) +3,286 $6.4K EDGAR
2019-06-03 SENS Grant (A) $0 EDGAR
2019-05-13 PhaseBio Pharmaceuticals Inc (PHAS) Delisted Grant (A) $0 EDGAR
2019-04-03 SENS Grant (A) +2,895 $6.7K EDGAR
2019-03-01 PhaseBio Pharmaceuticals Inc (PHAS) Delisted Grant (A) $0 EDGAR
2019-01-04 SENS Grant (A) +4,507 $12.1K EDGAR
2018-10-24 PhaseBio Pharmaceuticals Inc (PHAS) Delisted Mixed +2,303 $0 EDGAR
2018-10-03 SENS Grant (A) +2,670 $12.1K EDGAR
2018-07-05 SENS Grant (A) +2,737 $12.1K EDGAR
Showing 1120 of 26
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.